Delivery Order SPE2DB20D3505-SPE2DB22FU2P3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Anastrozole 1 mg tablets. The $1,650.89 firm-fixed price delivery order is not set aside and has an ultimate completion date of August 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical through December 2025 for providing a comprehensive...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,290.24 by the Defense Logistics Agency on January 12, 2026, for the supply of Anastrozole 1 mg tablets in quantities of 30 units. The contract carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be completed at the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 13, 2026....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,690.72, is for the delivery of 4,568,092,832 tablets of the prescription medication Arimidex (1 mg). The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,305.87 to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in a 30-count package. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by December 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,790.08 to Amerisourcebergen Drug Corp (parent company: Cencora, Inc.) on January 6, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by January 7, 2026. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) with a ceiling value of $35,911.43. This firm fixed-price, competitively awarded delivery order is set to be completed by January 8, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support federal medical supply needs, particularly for...
- The Defense Logistics Agency awarded a $59,781.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) with an ultimate completion date of December 23, 2025. This competitively awarded contract, issued without a set-aside designation, represents a single delivery order under AmerisourceBergen's existing relationship with DLA for pharmaceutical procurement. The company will perform this work from its corporate office in...
- The Defense Logistics Agency awarded a $5,731.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on December 15, 2025, with completion scheduled for December 16, 2025. This non-set-aside contract represents a routine pharmaceutical procurement fulfilling federal medical supply needs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and...
- This is a delivery order contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ARIMIDEX 1 MG TABLET 30S. The contract has a ceiling value of $42,252.83 and an ultimate completion date of September 17, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with the DLA Troop Support Medical being a significant customer. The company holds multiple Indefinite Delivery Contracts...
- The Defense Logistics Agency awarded a $29,791.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Arimidex 1 mg tablets, with an ultimate completion date of January 9, 2026. This non-set-aside contract was competitively awarded and performed from AmerisourceBergen's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems with...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FU2P3Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Anastrozole 1 mg tablets. The $4,266.59 firm fixed-price contract has a performance period ending on September 2, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is made under that larger IDC, enabling the DLA to efficiently procure essential medication for its facilities. The contract does not have a set-aside designation, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 9/1/22 |